Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Ali Behbahani occupies the position of Chairman at Nkarta, Inc. and General Partner of NEA Management Co. LLC.

He is also General Partner for New Enterprise Associates LLC and on the board of 16 other companies.

In the past Ali Behbahani was Consultant at The Medicines Co., Analyst at Lehman Brothers Asset Management LLC and Venture Associate at Morgan Stanley Venture Partners.

He received an undergraduate degree from Duke University, an MBA from The Wharton School of the University of Pennsylvania and a doctorate from Perelman School of Medicine.


Current positions of Ali Behbahani 
NameTitle Since
CRISPR Therapeutics AG
(Biotechnology & Medical Research)
Independent Non-Executive Director 2015
Monte Rosa Therapeutics, Inc.
(Biotechnology & Medical Research)
Director 2020
Nkarta, Inc.
(Biotechnology & Medical Research)
Chairman 2019
Adaptimmune Therapeutics plc
(Biotechnology & Medical Research)
Independent Non-Executive Director 2014
Black Diamond Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2018
Oyster Point Pharma, Inc.
(Biotechnology & Medical Research)
Director 2021
CVRx, Inc.
(Medical Equipment, Supplies & Distribution)
Independent Director 2013
Genocea Biosciences, Inc.
(Biotechnology & Medical Research)
Independent Director 2018
Rotation Medical, Inc. Director -
Ivantis, Inc. Director -
Minerva Surgical, Inc. Director -
Ocutherix, Inc. Director -
ClarVista Medical, Inc. Director -
Cardionomic, Inc. Director -
Arcellx, Inc. Director -
Spyglass Ophthalmics, Inc. Director -
Korro Bio, Inc. Director -
New Enterprise Associates LLC General Partner 2007
NEA Management Co. LLC General Partner 2018


Holdings of Ali Behbahani 
NameEquities%Valuation
Oyster Point Pharma, Inc. (OYST)
(Biotechnology & Medical Research)
10,0660.039%132,670 USD
CRISPR Therapeutics AG (CRSP)
(Biotechnology & Medical Research)
2700.0004%33,737 USD
Black Diamond Therapeutics, Inc. (BDTX)
(Biotechnology & Medical Research)
1,5610.0043%15,766 USD
Adaptimmune Therapeutics Plc00.0000%0 USD
Monte Rosa Therapeutics, Inc. (GLUE)
(Biotechnology & Medical Research)
00.0000%0 USD
Nkarta, Inc. (NKTX)
(Biotechnology & Medical Research)
00.0000%0 USD
Genocea Biosciences, Inc. (GNCA)
(Biotechnology & Medical Research)
00.0000%0 USD
CVRx, Inc. (CVRX)
(Medical Equipment, Supplies & Distribution)
00.0000%0 USD


Ali Behbahani: Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
RE
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/08MICHAEL O'LEARY : Exclusive-Ryanair ready to wait years for Boeing to cut prices, says O'Leary
RE
More news


© 2021 People and Ownership :   
Ali Behbahani : Connections